Neonatal screening program for five conditions in Honduras

We present the initial results of a neonatal screening program in part of the public health system in Honduras, that is, the Honduran Social Security Institute. The program design includes steps from neonatal bloodspot in the first newborn days to evaluation and treatment when necessary. In 2018 and...

Full description

Saved in:
Bibliographic Details
Published in:Journal of community genetics 2021-07, Vol.12 (3), p.389-395
Main Authors: Buckley, Michelle Melissa Miralda, Aguilar, Lindsay Borjas, Lainez, Rosibel Colindres, Valenzuela, Hector Joaquin Alvarado, Ponce, Fernando, Melo, Débora Gusmão
Format: Article
Language:English
Subjects:
Biomedical and Life Sciences
Biomedicine
Cystic fibrosis
Epidemiology
Galactosemia
Gene Function
Gene Therapy
Human Genetics
Hyperplasia
Hypothyroidism
Neonates
Original
Original Article
Phenylketonuria
Public Health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We present the initial results of a neonatal screening program in part of the public health system in Honduras, that is, the Honduran Social Security Institute. The program design includes steps from neonatal bloodspot in the first newborn days to evaluation and treatment when necessary. In 2018 and 2019, 19,911 newborns were tested for hypothyroidism, cystic fibrosis, galactosemia, phenylketonuria, and adrenal hyperplasia. Abnormalities were identified in 18 newborns, corresponding to a prevalence of 9:10,000. Considering all births in Honduras, the estimated coverage of screening ranged between 4.4 and 5.7%. These results reinforce the need to expand and consolidate neonatal screening.
ISSN:1868-310X
1868-6001
DOI:10.1007/s12687-021-00506-7